INS and fatty liver disease: Higher β‐carotenoid intake may reduce risk for NAFLD and the progression of simple hepatic steatosis to nonalcoholic steatohepatitis, through several different pathways, including the attenuation of inflammation and oxidative stress in the liver, with downstream effects on secretion of pro-inflammatory cytokines by hepatic macrophages, immune infiltration, and insulin sensitivity71.